IL-17A-dependent CD4+CD25+ regulatory T cells promote immune privilege of corneal allografts

Khrishen Cunnusamy, Peter W. Chen, Jerry Y. Niederkorn

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

IL-17A is a proinflammatory cytokine that has received attention for its role in the pathogenesis of several autoimmune diseases. IL-17A has also been implicated in cardiac and renal allograft rejection. Accordingly, we hypothesized that depletion of IL-17A would enhance corneal allograft survival. Instead, our results demonstrate that blocking IL-17A in a mouse model of keratoplasty accelerated the tempo and increased the incidence of allograft rejection from 50 to 90%. We describe a novel mechanism by which CD4 +CD25+ regulatory T cells (Tregs) respond to IL-17A and enhance corneal allograft survival. Our findings suggest the following: 1) IL-17A is necessary for ocular immune privilege; 2) IL-17A is not required for the induction of anterior chamber-associated immune deviation; 3) Tregs require IL-17A to mediate a contact-dependent suppression; 4) corneal allograft Tregs suppress the efferent arm of the immune response and are Ag specific; 5) Tregs are not required for corneal allograft survival beyond day 30; and 6) corneal allograft-induced Treg-mediated suppression is transient. Our findings identify IL-17A as a cytokine essential for the maintenance of corneal immune privilege and establish a new paradigm whereby interplay between IL-17A and CD4 +CD25+ Tregs is necessary for survival of corneal allografts.

Original languageEnglish (US)
Pages (from-to)6737-6745
Number of pages9
JournalJournal of Immunology
Volume186
Issue number12
DOIs
StatePublished - Jun 15 2011

Fingerprint

Interleukin-17
Regulatory T-Lymphocytes
Allografts
Cytokines
Corneal Transplantation
Anterior Chamber
Autoimmune Diseases
Arm
Maintenance
Kidney

ASJC Scopus subject areas

  • Immunology

Cite this

IL-17A-dependent CD4+CD25+ regulatory T cells promote immune privilege of corneal allografts. / Cunnusamy, Khrishen; Chen, Peter W.; Niederkorn, Jerry Y.

In: Journal of Immunology, Vol. 186, No. 12, 15.06.2011, p. 6737-6745.

Research output: Contribution to journalArticle

@article{aa9ea1ad205a47df8670655f89ec6ad8,
title = "IL-17A-dependent CD4+CD25+ regulatory T cells promote immune privilege of corneal allografts",
abstract = "IL-17A is a proinflammatory cytokine that has received attention for its role in the pathogenesis of several autoimmune diseases. IL-17A has also been implicated in cardiac and renal allograft rejection. Accordingly, we hypothesized that depletion of IL-17A would enhance corneal allograft survival. Instead, our results demonstrate that blocking IL-17A in a mouse model of keratoplasty accelerated the tempo and increased the incidence of allograft rejection from 50 to 90{\%}. We describe a novel mechanism by which CD4 +CD25+ regulatory T cells (Tregs) respond to IL-17A and enhance corneal allograft survival. Our findings suggest the following: 1) IL-17A is necessary for ocular immune privilege; 2) IL-17A is not required for the induction of anterior chamber-associated immune deviation; 3) Tregs require IL-17A to mediate a contact-dependent suppression; 4) corneal allograft Tregs suppress the efferent arm of the immune response and are Ag specific; 5) Tregs are not required for corneal allograft survival beyond day 30; and 6) corneal allograft-induced Treg-mediated suppression is transient. Our findings identify IL-17A as a cytokine essential for the maintenance of corneal immune privilege and establish a new paradigm whereby interplay between IL-17A and CD4 +CD25+ Tregs is necessary for survival of corneal allografts.",
author = "Khrishen Cunnusamy and Chen, {Peter W.} and Niederkorn, {Jerry Y.}",
year = "2011",
month = "6",
day = "15",
doi = "10.4049/jimmunol.1100101",
language = "English (US)",
volume = "186",
pages = "6737--6745",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "12",

}

TY - JOUR

T1 - IL-17A-dependent CD4+CD25+ regulatory T cells promote immune privilege of corneal allografts

AU - Cunnusamy, Khrishen

AU - Chen, Peter W.

AU - Niederkorn, Jerry Y.

PY - 2011/6/15

Y1 - 2011/6/15

N2 - IL-17A is a proinflammatory cytokine that has received attention for its role in the pathogenesis of several autoimmune diseases. IL-17A has also been implicated in cardiac and renal allograft rejection. Accordingly, we hypothesized that depletion of IL-17A would enhance corneal allograft survival. Instead, our results demonstrate that blocking IL-17A in a mouse model of keratoplasty accelerated the tempo and increased the incidence of allograft rejection from 50 to 90%. We describe a novel mechanism by which CD4 +CD25+ regulatory T cells (Tregs) respond to IL-17A and enhance corneal allograft survival. Our findings suggest the following: 1) IL-17A is necessary for ocular immune privilege; 2) IL-17A is not required for the induction of anterior chamber-associated immune deviation; 3) Tregs require IL-17A to mediate a contact-dependent suppression; 4) corneal allograft Tregs suppress the efferent arm of the immune response and are Ag specific; 5) Tregs are not required for corneal allograft survival beyond day 30; and 6) corneal allograft-induced Treg-mediated suppression is transient. Our findings identify IL-17A as a cytokine essential for the maintenance of corneal immune privilege and establish a new paradigm whereby interplay between IL-17A and CD4 +CD25+ Tregs is necessary for survival of corneal allografts.

AB - IL-17A is a proinflammatory cytokine that has received attention for its role in the pathogenesis of several autoimmune diseases. IL-17A has also been implicated in cardiac and renal allograft rejection. Accordingly, we hypothesized that depletion of IL-17A would enhance corneal allograft survival. Instead, our results demonstrate that blocking IL-17A in a mouse model of keratoplasty accelerated the tempo and increased the incidence of allograft rejection from 50 to 90%. We describe a novel mechanism by which CD4 +CD25+ regulatory T cells (Tregs) respond to IL-17A and enhance corneal allograft survival. Our findings suggest the following: 1) IL-17A is necessary for ocular immune privilege; 2) IL-17A is not required for the induction of anterior chamber-associated immune deviation; 3) Tregs require IL-17A to mediate a contact-dependent suppression; 4) corneal allograft Tregs suppress the efferent arm of the immune response and are Ag specific; 5) Tregs are not required for corneal allograft survival beyond day 30; and 6) corneal allograft-induced Treg-mediated suppression is transient. Our findings identify IL-17A as a cytokine essential for the maintenance of corneal immune privilege and establish a new paradigm whereby interplay between IL-17A and CD4 +CD25+ Tregs is necessary for survival of corneal allografts.

UR - http://www.scopus.com/inward/record.url?scp=79959566615&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959566615&partnerID=8YFLogxK

U2 - 10.4049/jimmunol.1100101

DO - 10.4049/jimmunol.1100101

M3 - Article

C2 - 21551366

AN - SCOPUS:79959566615

VL - 186

SP - 6737

EP - 6745

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 12

ER -